NR1I2 and COVID-19: DPTSGs associated with biological processes of “response to chemical” and pathways of “Drug metabolism - cytochrome P450”, “nuclear receptors meta-pathway”, “pregnane X receptor pathway”, and “COVID-19 adverse outcome pathway”